Recent Study Shows Genotype-Guided Antiplatelet Therapy Reduces Heart Event Risk in High-Risk Patients

Recent Study Shows Genotype-Guided Antiplatelet Therapy Reduces Heart Event Risk in High-Risk Patients
Publication Date: 
10/11/2024